(Q43855204)

27 November 2017

title

The use of "Catapres" in the treatment of severe hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5348653

5 May 2023

author name string

J. Raftos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5348653

5 May 2023

language of work or name

English

0 references

publication date

1 October 1969

1 reference

full work available at URL

27 November 2017

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1969.tb107345.x

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

https://onlinelibrary.wiley.com/doi/full-xml/10.5694/j.1326-5377.1969.tb107345.x

5 May 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

Medical Journal of Australia

5 May 2023

published in

1 reference

27 November 2017

volume

2

1 reference

27 November 2017

issue

14

1 reference

27 November 2017

page(s)

684-687

1 reference

Guanethidine in treatment of hypertension

27 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres)

5 May 2023

2

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

The antihypertensive effects of an imidazoline compound.

5 May 2023

3

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.

5 May 2023

6

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

A long-term study with pargyline in the treatment of hypertension

5 May 2023

7

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan).

5 May 2023

11

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1969.TB107345.X

5 May 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5348653

5 May 2023

1 reference